Holly Martinez Interviewed by The Portland Business Journal—Why Psilocybin Should Not Be A Schedule 1 Drug
Holly Martinez was interviewed by the Portland Business Journal for a Q&A feature article covering why psilocybin should not be a Schedule 1 drug. Holly, a litigation lawyer, is a member of a firm legal team representing a Seattle doctor in a case that is seeking to get the Drug Enforcement Administration to reclassify psilocybin as a Schedule 2 drug.
Click here to read the full article in the Portland Business Journal.
Print and share
Contact
Notice
Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.